UPDATE 3-Samsung's Bioepis considers Nasdaq IPO, seeks funds for product development
June 29, 2015 at 04:30 AM EDT
* Samsung Bioepis seen having $7 bln market cap -media (Adds revenue target, product pipeline in paragraphs 10-11)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.